The performance of the radiomics model in predicting ER/PR status in breast cancer patients was confirmed using the validation set, yielding an AUC of 0.93 (95% CI, 0.84–0.98, std error of 0.02) (Figure 4). The gene discussed is PGR; the disease is breast carcinoma.